Na Xu
Impact in
-
- Viral Infections and Immunology Research
-
- Renal and Vascular Pathologies
- Aortic aneurysm repair treatments
Papers in
-
- Sarcoma Diagnosis and Treatment 2
- Oncology 5
- Co-authors
- Tomáš Roubíček (2 shared papers)Vesna D. Garovic (1 shared paper)Garvan C. Kane (1 shared paper)Anthony W. Stanson (1 shared paper)Yi Yao (4 shared papers)Bo Xu (4 shared papers)Xiaofang Tang (6 shared papers)Jing Yang (1 shared paper)
- Journals
- Medicine (4 papers)Frontiers in Oncology (2 papers)Journal of Virology (1 paper)Journal of Cardiology (1 paper)Blood (1 paper)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Na Xu
40 papers receiving 468 citations
Peers
Comparison fields: 5 of 72
- Cardiology and Cardiovascular Medicine 77
- Pulmonary and Respiratory Medicine 111
- Obstetrics and Gynecology 25
- Nephrology 20
- Hepatology 20
Countries citing papers authored by Na Xu
This map shows the geographic impact of Na Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Na Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Na Xu more than expected).
Fields of papers citing papers by Na Xu
This network shows the impact of papers produced by Na Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Na Xu. The network helps show where Na Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Na Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 88 | |
| 2 | 2020 | 49 | |
| 3 | 2023 | 40 | |
| 4 | 2018 | 40 | |
| 5 | 2016 | 35 | |
| 6 | 2019 | 33 | |
| 7 | 2018 | 28 | |
| 8 | 2015 | 16 | |
| 9 | Lunar phases, myocardial infarction and hemorrheological character. A Western medical study combined with appraisal of the related traditional Chinese medical theory. | 1989 | 14 |
| 10 | 2021 | 12 | |
| 11 | 2014 | 12 | |
| 12 | 2019 | 11 | |
| 13 | 2019 | 10 | |
| 14 | 2018 | 9 | |
| 15 | 2020 | 9 | |
| 16 | 2021 | 7 | |
| 17 | 2022 | 7 | |
| 18 | 2023 | 6 | |
| 19 | 2019 | 5 | |
| 20 | 2010 | 5 |
About Na Xu
Na Xu is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Epidemiology, Rheumatology and Hematology, having authored 46 papers that have together received 483 indexed citations. Recurring topics across this work include Gout, Hyperuricemia, Uric Acid (4 papers), Chronic Myeloid Leukemia Treatments (3 papers), Hepatitis B Virus Studies (2 papers), Systemic Lupus Erythematosus Research (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Adipokines, Inflammation, and Metabolic Diseases (2 papers), Sarcoma Diagnosis and Treatment (2 papers) and Folate and B Vitamins Research (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (77 citations), Pulmonary and Respiratory Medicine (111 citations), Obstetrics and Gynecology (25 citations), Nephrology (20 citations) and Hepatology (20 citations). Na Xu has collaborated with scholars based in China, United States and France. Frequent co-authors include Tomáš Roubíček, Vesna D. Garovic, Garvan C. Kane, Anthony W. Stanson, Yi Yao, Bo Xu, Xiaofang Tang, Jing Yang, Ying Shi and Baisong Zheng. Their work appears in journals such as Medicine, Frontiers in Oncology, Journal of Virology, Journal of Cardiology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.